Meet SeqOne in Granada! 🇪🇸 The SeqOne team is looking forward to the XXX Congreso AEGH (Asociación Española de Genética Humana), from April 15 - 17 in Granada. 📅 Don’t miss our talk on April 15 at 2 PM with experts Valeria Romanelli and Marcela Galvez (Gencell), “Diagnóstico acelerado para una mejor atención al paciente gracias al rendimiento de DiagAI”. 📍 Come meet us at booth 33 to get a first-hand demo and discover how we help labs in Spain and around the world streamline variant interpretation: ▶️ One platform for all your genomics needs: somatic, germline, short and long-read. Fully automated, end-to-end, and workflow agnostic. ▶️ From raw data to clinical insights in a single score: SeqOne's DiagAI Score turns complex genomic data into interpretable, reproducible pathogenicity calls. ▶️ Come see for yourself: Test-drive SeqOne for free for 30 days, with your own data, expert support, and seamless integration. … and more! Whether it's a quick hello, demo, or deep dive, we look forward to connecting with fellow genomics enthusiasts. #Genomics #NGS #PrecisionMedicine #Bioinformatics #VariantInterpretation #ClinicalGenomics #GeneticaHumana
SeqOne
Recherche en biotechnologie
Montpellier, Occitanie 12 235 abonnés
From Genome to Personalized Medicine
À propos
SeqOne is a deep-tech company committed to making personalized medicine a reality. Its AI-powered genomic analysis platform provides clinical decision-support tools that enable molecular laboratories to deliver fast, accurate, and scalable analysis of genetic data for applications in oncology, rare and inherited diseases, and infectious diseases. The company now serves a global customer base of healthcare providers and biopharmaceutical companies across more than 30 countries, supported by strong industry partnerships and an expanding presence in the US market. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, Software Club, and Supernova Invest.
- Site web
-
www.seqone.com
Lien externe pour SeqOne
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Montpellier, Occitanie
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2017
- Domaines
- Precision Medicine, Genetics, Genomics, NGS, Bioinformatics, Transcriptomics, Epigenomics, Companion Diagnostics, IVD et CE IVDR
Lieux
-
Principal
Obtenir l’itinéraire
22, Rue Durand
34000 Montpellier, Occitanie, FR
-
Obtenir l’itinéraire
22, Rue Durand
34000 Montpellier, Occitanie, FR
Employés chez SeqOne
Nouvelles
-
High-throughput sequencing is a reality. Consistent, scalable interpretation is the next frontier. 🧬 For reference centers running Comprehensive Genomic Profiling (CGP) across multiple tumor types, fragmented workflows often limit efficiency. Join us on April 22 to hear how the University Hospital of Split (KBC Split) modernized their solid tumor NGS interpretation workflow and validated it for routine clinical use. 📣 Attend our webinar: "Implementing a Scalable Automated CGP Workflow in Routine Clinical Practice" Expert speakers: • Nenad Kunac, MD, PhD – Head of Molecular Pathology, University Hospital of Split • Daiana Ganiewich – Director of Product Management, Oncology, SeqOne What we’ll cover: ✅ Unified Workflow: Interpreting SNVs, indels, fusions, MSI, and TMB in one place. ✅ Validation Strategy: Ensuring concordance and clinical reliability. ✅ Real-World Scaling: Practical lessons from a high-complexity hospital. 🗓 April 22 | 8 AM PT • 11 AM ET • 5 PM CET Register here ➡️ https://lnkd.in/eK-UCxJZ #ComprehensiveGenomicProfiling #PrecisionOncology #NGS #ClinicalGenomics #MolecularDiagnostics #SeqOne
-
-
Choosing a bioinformatics partner in 2026? Here's a framework to help you decide with confidence. 🧬 Did you miss our webinar, "Beyond the Black Box: A Framework for Evaluating Clinical Bioinformatics Platforms in 2026"? Catch the replay with experts Jeanette McCarthy and Mitch Nemcek. Learn how to build a robust evaluation framework for your lab, from navigating variant-level complexity to benchmarking platform transitions with real-world operational data. Watch the replay on-demand: https://lnkd.in/eKnP8Pkp #ClinicalBioinformatics #Genomics #NGS #PrecisionMedicine #VariantInterpretation
-
-
The new Congenica website is live, and we couldn't be prouder to have this exceptional team as part of SeqOne. With roots in the Wellcome Sanger Institute, over a decade of clinical excellence, and the trust of NHS Genomic Medicine Services, Congenica brings a depth of heritage and expertise that strengthens everything we do together. This is just the beginning. Take a look: www.congenica.com
We're excited to share that Congenica has a brand new home online. Our refreshed website reflects a significant milestone for us: joining the SeqOne family. This partnership brings greater capacity, deeper innovation, and long-term stability to the labs and clinicians who depend on us every day. Our commitment to the UK's genomic medicine community remains the same. Born from the Wellcome Sanger Institute and trusted across NHS Genomic Medicine Services, Congenica is still the partner you know and rely on. Together with SeqOne, we're now part of a combined force of 190+ labs across 35+ countries, backed by €20M in recent funding and a 125+ person team. Our platform is expanding from its proven rare disease foundations into oncology and infectious disease, all on a single clinical-grade platform. Same deep heritage. Same trusted team. A much bigger vision. Explore the new site: www.congenica.com #Genomics #ClinicalGenomics #Congenica #SeqOne #PrecisionMedicine #GenomicMedicine
-
-
Your bioinformatics skills can help patients get the right diagnosis. That's the work we do at SeqOne every day. We're hiring a Senior Bioinformatician, Customer Care. Our platform powers genomic analysis for 190+ clinical labs across 30+ countries, from rare disease diagnostics to oncology profiling. In this role, you'll be the expert our customers trust with their hardest questions. What you'll do: 🔬 Generate CNV/MSI/Methylation baselines and manage variant database migrations 📣 Translate complex genomic findings into clear guidance for clinical teams worldwide 📈 Feed real-world insights back to R&D and Product to shape our roadmap 🧬 Investigate variant-calling discrepancies and trace root causes in pipeline code What we're looking for: PhD/MSc in bioinformatics or related field, 5+ years in genomics, 2+ years customer-facing, and strong skills in Python, R, GATK, and cloud environments. 🌍 Fully remote (US, Canada, or Europe) We'd love to hear from you. 🔗 Apply here: https://lnkd.in/ebimmMnT #Bioinformatics #Genomics #Hiring #RemoteWork #SeqOne #NGS #ClinicalGenomics #PersonalizedMedicine
-
-
Proud to contribute to this Spanish-language webinar alongside Agilent Technologies and Analytical Technologies S.A., bringing together Alejandro X. Rivera Gonzalez (Genomic Field Applications Scientist, Agilent Technologies) and Daiana Ganiewich (Director of Product Management Oncology, SeqOne) to explore how liquid biopsy is redefining precision medicine in cancer. Tune in on March 26, 2026: https://lnkd.in/emegnnks #LiquidBiopsy #PrecisionOncology #NGS #cfDNA #Agilent #SeqOne
-
-
Empowering clinicians across the Caribbean with smarter genomic insights 🌍 We're excited to announce our partnership with Analogic Solutions, a leading NGS distributor across the Caribbean. Hear from the Analogic Solutions team: "Our decision to partner with SeqOne is a strategic move to bridge the gap between high-throughput sequencing hardware and actionable clinical insights. As a laboratory sales leader representing Agilent Technologies and a diverse range of NGS platforms, we recognize that the primary challenge for modern labs is no longer just generating data, but accurately interpreting it. SeqOne's state-of-the-art, AI-driven genomic analysis platform complements our existing portfolio by providing a seamless, end-to-end workflow from library preparation to final clinical report — a validated, high-performance solution that maximizes diagnostic yield while significantly reducing turnaround times.” Together, we're committed to bringing the local support and advanced tools that clinicians and labs across the region need to drive diagnostic excellence. Reach out to Analogic Solutions or SeqOne to learn more! #Genomics #NGS #Bioinformatics #PrecisionMedicine #Partnership #AnalogicSolutions #SeqOne #Caribbean
-
-
Live from #ACMGMtg26! With ACMG's latest statement highlighting key considerations for NGS-based detection of CNVs and structural variants, the timing couldn't be better for this conversation. Our Director of Field Application Science for North America, Mitch Nemcek, is on stage walking through CNV and SV interpretation in clinical genomics, from detection to large variant visualization, regardless of your wet lab setup. He's also diving into a real-world example using Twist Bioscience's CNV Backbone Spike-in Panel to show how SeqOne handles the full journey end to end. Come see it for yourself at booth 1722, or explore our solutions at www.seqone.com!
-
-
We're proud to share this case study with Genekor Medical S.A. in Romania. They chose SeqOne for its ability to take raw FASTQ data through to a reliable Genomic Instability Score, with an automated pipeline that fits routine clinical volumes. Over the past year, they've turned HRD testing into an everyday workflow and published the research to back it up. As Amalia Chirnogea, Molecular Biology Coordinator at Genekor, puts it: "SeqOne played an important role in bridging the gap between high level research and routine clinical practice. This has been especially valuable in Romania, where access to cost effective yet reliable HRD testing is critical for expanding precision oncology." That's a real win for patients. Thank you to the Genekor Medical team for their trust and collaboration, and to our partner VARELAS S.A. CHEMICALS AND DIAGNOSTICS for connecting us on the ground. 🔗 https://lnkd.in/eKcNgzJQ #PrecisionOncology #HRDTesting #GenomicMedicine #MolecularDiagnostics #ClinicalGenomics
-
-
Let's go! We're kicking off #ACMG2026 and could not be more excited to be in Baltimore this week! 🎉 If you're at the congress, come say hi. We'd love to meet you at📍Booth 1722. Swing by for a live demo and see how SeqOne is helping labs scale diagnostic precision with explainable AI: → AI-powered variant interpretation for rare disease & complex genomics → DiagAI: transparent, explainable scoring (0 to 100) built for clinical workflows → An end-to-end platform designed for high-throughput, high-stakes diagnostics 🔬 Catch our science in the poster hall Alexandre Boulat will be presenting two posters on March 12 at 10:30 AM: • "Clinical Evaluation of DiagAI for Streamlined Variant Interpretation in Whole Genome Sequencing of Genomics England Patients" (P259) • "Detection and Classification of Uniparental Disomy from Clinical Whole-Exome Data Using the GermVar Pipeline" (P621) 🎤 And don't miss our Exhibit Theater session with Mitch Nemcek: "From Complexity to Clarity: Streamlining CNV and SV Interpretation in Clinical Genomics" 📅 Friday, March 13 | 12:30 to 1:00 PM | Exhibit Theater 1 Whether you want to talk variant interpretation, pipeline optimization, or just geek out about genomics, we're here for it. Come find us! #ACMG2026 #Genomics #AI #Bioinformatics #ClinicalGenomics #SeqOne #DiagAI #RareDisease #Diagnostics #Innovation
-
Pages similaires
Parcourir les offres d’emploi
Financement
Dernier round
Série inconnue22 563 864,00 $US